cDNA cloning and localization of OCRL-1 in rabbit kidney

American Journal of Physiology - Renal Physiology

Volumn 273, Issue 5 42-5, 1997, Pages

  Erb, Brian C ^b   Velázquez, Heino ^b   Gisser, Monique ^b   Shugrue, Christine A ^b   Reilly, Robert F ^a  

^a UNIVERSITY OF COLORADO   (United States)

^b NONE

Author keywords

Fanconi's syndrome; Inositol polyphosphate 5 phosphatase; Lowe's syndrome; Nephron segment reverse transcription polymerase chain reaction

Indexed keywords

COMPLEMENTARY DNA; INOSITOL POLYPHOSPHATE;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; GENE LOCATION; GENE MUTATION; KIDNEY CORTEX; KIDNEY MEDULLA; LOWE SYNDROME; MOLECULAR CLONING; NEPHRON; NONHUMAN; PRIORITY JOURNAL; RABBIT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEQUENCE HOMOLOGY;

EID: 0030669453     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.1997.273.5.f790     Document Type: Article

References (18)

1. Abbassi, V., C. U. Lowe, and P. L. Calcagno. Oculo-cerebrorenal syndrome. Am. J. Dis. Child. 115: 145-168, 1968.
2. Attree, O., I. M. Olivos, I. Okabe, L. C. Bailey, D. L. Nelson, R. A. Lewis, R. R. McInnes, and R. L. Nussbaum. The Lowe's oculocerebrorenal syndrome gene encodes a protein highly ho mologous to inositol polyphosphate-5-phosphatase. Nature 358: 239-242, 1992.
3. Brown, H. A., S. Gutowski, C. R. Moomaw, C. Slaughter, and P. C. Sternweis. ADP-ribosylation factor, a small GTP-dependent regulatory protein stimulates phospholipase D activity. Cell 75: 1137-1144, 1993.
4. Charnas, L. R., I. Bernardini, D. Rader, J. M. Hoeg, and W. A. Gaul. Clinical and laboratory findings in the oculocerebrorenal syndrome of Lowe, with special reference to growth and renal function. N. Engl. J. Med. 324: 1318-1325, 1991.
5. De Camilli, P., S. D. Emr, P. S. McPherson, and P. Novick. Phosphoinositides as regulators in membrane traffic. Science 271: 1533-1539, 1996.
6. Donaldson, J. G., D. Cassel, R. A. Kahn, and R. D. Klausner. ADP-ribosylation factor, a small GTP-binding protein, is required for binding of the coatomer protein β-COP to Golgi membranes. Proc. Natl. Acad. Sci. USA 89: 6408-6412, 1992.
7. + RNA from cells in monolayer. Endocrinology 127: 2038-2040, 1990.
8. Kahn, R. A., J. K. Yucel, and V. Malhotra. ARF signaling: a potential role for phospholipase D in membrane traffic. Cell 75: 1045-1048, 1993.
9. Leahey, A.-M., L. R. Charnas, and R. L. Nussbaum. Nonsense mutations in the OCRL-1 gene in patients with the oculocerebrorenal syndrome of Lowe. Hum. Mol. Genet. 2: 461-463, 1993.
10. Lowe, C. U., M. Terrey, and E. A. MacLachlan. Organic-aciduria, decreased renal ammonia production, hydrophthalmos, and mental retardation. Am. J. Dis. Child. 83: 164-184, 1952.
11. Okabe, I., O. Attree, L. C. Bailey, D. L. Nelson, and R. L. Nussbaum. Isolation of cDNA sequences around the chromosomal breakpoint in a female with Lowe syndrome by direct screening of cDNA libraries with yeast artificial chromosomes. J. Inherit. Metab. Dis. 15: 526-531, 1992.
12. 1). Am. J. Physiol. 261 (Renal Fluid Electrolyte Physiol. 30): F1088-F1094, 1991.
13. 2+ exchanger. Am. J. Physiol. 262 (Renal Fluid Electrolyte Physiol. 31): F1105-F1109, 1992.
14. Rutsaert, J., A. Segers-Cadranel, and P. Potvliege. Lowe's syndrome: pathologic studies of four cases. Pathol. Eur. 7: 249-262, 1972.
15. Schoen, E. J. Lowe's syndrome: abnormalities in renal tubular function in combination with other congenital defects. Am. J. Med. 27: 781-792, 1959.
16. Sliman, G. A., W. D. Winters, D. W. Shaw, and E. D. Avner. Hypercalciuria and nephrocalcinosis in the oculocerebrorenal syndrome. J. Urol. 153: 1244-1246, 1995.
17. Suchy, S. F., I. M. Olivos-Glander, and R. L. Nussbaum. Lowe syndrome, a deficiency of a phosphatidylinositol 4,5-bisphosphate 5-phosphatase in the Golgi apparatus. Hum. Mol. Genet. 4: 2245-2250, 1995.
18. Zhang, X., A. B. Jefferson, V. Auethavekiat, and P. W. Majerus. The protein deficient in Lowe syndrome is a phosphatidylinositol-4,5-bisphosphate 5-phosphatase. Proc. Natl. Acad. Sci. USA 92: 4853-4856, 1995.